SAM
ALXN

Symphony Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Symphony Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7,136
Closed -$1.18M – 457
2014
Q3 		$1.18M Sell
7,136
-1,881
-21% -$309K 0.12% 163
2014
Q2 		$1.41M Buy
9,017
+110
+1% +$17.4K 0.15% 170
2014
Q1 		$1.35M Sell
8,907
-94
-1% -$14.9K 0.13% 179
2013
Q4 		$1.2M Buy
9,001
+4,348
+93% +$522K 0.09% 191
2013
Q3 		$541K Buy
+4,653
New +$511K 0.05% 294

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Symphony Asset Management's ALXN Position: Q4 2014 in Review

Symphony Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q4 2014, closing a stake of 7,136 shares — an estimated $1.18M sold.

Symphony Asset Management first reported a position in ALXN in Q3 2013 and held it in 5 quarters. The position peaked at $1.41M in Q2 2014. 579 funds tracked by Wall St. Rank hold ALXN as of Q4 2014.

  • Symphony Asset Management reported no remaining Alexion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Symphony Asset Management sold 7,136 Alexion Pharmaceuticals shares in Q4 2014, an estimated $1.18M.
  • Symphony Asset Management first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Symphony Asset Management's Alexion Pharmaceuticals position peaked at $1.41M in Q2 2014.
  • 579 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2014.

Based on Symphony Asset Management's 13F filing for Q4 2014, filed 9 Feb 2015.